Case Report of Nerve Root Sleeve Reinforcement and Reconstruction and Sacral Canal Plasty for the Treatment of Sacral Canal

Sponsor
Peking University Third Hospital (Other)
Overall Status
Completed
CT.gov ID
NCT04960462
Collaborator
(none)
24
1
8.9
2.7

Study Details

Study Description

Brief Summary

A retrospective study of the changes in the VAS scores and imaging examinations after the reconstruction and reinforcement of nerve root sleeves and caudal angioplasty for the treatment of sacral cysts from August 2017 to January 2018 was used to evaluate the efficacy of the surgical prescription.

Condition or Disease Intervention/Treatment Phase
  • Procedure: nerve root sleeve reinforcement

Detailed Description

Objective: To clarify the curative effect of nerve root sleeve reconstruction and reinforcement and caudal plasty in the treatment of sacral cysts Design: A retrospective study of the changes in the VAS score and imaging examinations after the reconstruction and reinforcement of nerve root sleeves and sacral canoplasty for the treatment of sacral cysts from August 2017 to January 2018 to evaluate the efficacy of the surgical prescription.

Study Design

Study Type:
Observational
Actual Enrollment :
24 participants
Observational Model:
Case-Only
Time Perspective:
Retrospective
Official Title:
Case Report of Nerve Root Sleeve Reinforcement and Reconstruction and Sacral Canal Plasty for the Treatment of Sacral Canal
Actual Study Start Date :
Aug 1, 2017
Actual Primary Completion Date :
Jan 30, 2018
Actual Study Completion Date :
Apr 30, 2018

Arms and Interventions

Arm Intervention/Treatment
the treatment of sacral cysts in patients with sacral cysts by using nerve root sleeve reinforcement

The clinical data of patients with sacral cysts treated with nerve root sleeve reinforcement and reconstruction of the sacral canal cyst were summarized and followed up from 3 to 6 months after the operation to form a case summary and report.

Procedure: nerve root sleeve reinforcement
treatment of sacral cysts in patients with sacral cysts by using nerve root sleeve reinforcement

Outcome Measures

Primary Outcome Measures

  1. Symptomatic nerve root cyst diagnosed by MRI [2017/08-2018/01]

    The capsule of the cyst is intact and the sacral lamina is not defective ,No other diseases of the nervous system, pelvic floor and important organs Reconstruction of patients with artificial dural nerve root sleeve reinforcement

Eligibility Criteria

Criteria

Ages Eligible for Study:
N/A and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No

Inclusion Criteria:a) Symptomatic nerve root cyst diagnosed by MRI b) The capsule of the cyst is intact and the sacral lamina is not defective c) No other diseases of the nervous system, pelvic floor and important organs d) Reconstruction of patients with artificial dural nerve root sleeve reinforcement -

Exclusion Criteria:a) Non-radiotomy cyst or asymptomatic cyst b) The cyst causes severe bone erosion to lamina absorption c) Combined with other diseases of the nervous system, pelvic floor and important organs d) Those who have not used artificial dura mater for nerve root sleeve reinforcement and reconstruction

-

Contacts and Locations

Locations

Site City State Country Postal Code
1 Peking University Third Hospital Beijing China

Sponsors and Collaborators

  • Peking University Third Hospital

Investigators

  • Study Chair: bin liu, Peking University Third Hospital

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Peking University Third Hospital
ClinicalTrials.gov Identifier:
NCT04960462
Other Study ID Numbers:
  • M2018064
First Posted:
Jul 13, 2021
Last Update Posted:
Jul 13, 2021
Last Verified:
Jan 1, 2017
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Peking University Third Hospital
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jul 13, 2021